McNeilab, Inc. v. North River Insurance

645 F. Supp. 525
CourtDistrict Court, D. New Jersey
DecidedOctober 31, 1986
DocketCiv. A. 82-3934
StatusPublished
Cited by39 cases

This text of 645 F. Supp. 525 (McNeilab, Inc. v. North River Insurance) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McNeilab, Inc. v. North River Insurance, 645 F. Supp. 525 (D.N.J. 1986).

Opinion

OPINION

BARRY, District Judge.

Plaintiff in this action, McNeilab, Inc., is and has been since 1959 a wholly-owned subsidiary of Johnson & Johnson, 1 a multi-national, multi-billion dollar corporation involved primarily in the health care business. Since 1955, plaintiff has been engaged in the manufacture and sale of acetaminophen, an internal analgesic for temporary relief of pain and fever, which it has marketed under the trade name “Tylenol”.

The nation was stunned when, between September 29 and October 1, 1982, seven persons in the Chicago area died after ingesting Extra Strength Tylenol capsules laced with cyanide. Acting swiftly and efficiently to protect the public, to dissipate fear, and to clear the shelves of Tylenol so that it could quickly remarket a product in which the public would have confidence, Johnson & Johnson, between September 30 and October 7, 1982 and without consultation at any time with its insurers, undertook and funded a host of actions. Tylenol capsules and certain other McNeilab products were withdrawn from the market in the United States and seven foreign countries; the withdrawn Tylenol capsules were tested; the source of the tampering was investigated; non-tamper resistant packaged products were destroyed; tamper resistant packaging was developed; consumer studies and surveys were performed; an enormous number of reassurance messages were placed in print and on television and teleconferences were conducted; and a consumer research and exchange campaign as well as a campaign which enabled consumers to redeem coupons for tablet products issued during the crisis were launched. These actions were so successful that Tylenol not only regained but in short order exceeded its former share of the market. Without exception, those who have studied what took place during this period of time have concluded that, whatever the motive, no further deaths occurred 2 and Johnson & Johnson with its brilliant marketing strategy scored a major business coup.

This action began as a two-count complaint in which plaintiff, a named insured under the policy issued to Johnson & Johnson, sued nine of its insurers to recover *528 costs related to the recall. Those costs have at various times been estimated from $40,000,000 to $150,000,000 and it now appears that the appropriate figure is approximately $100,000,000, a figure which plaintiff proclaims, rather proudly, “spared” the insurers from having to assume the defense of additional liability actions with potential recoveries in untold millions, of dollars. I note, albeit parenthetically at this juncture, that Johnson & Johnson spent this $100,000,000 to mitigate damages on a liability it has claimed from day one does not exist. Stated somewhat differently, not believing it was liable, Johnson & Johnson could not have believed it was mitigating damages.

The first count of the complaint, the count before me now, seeks a determination that Johnson & Johnson’s excess and umbrella liability insurers — defendants North River Insurance Company, Transit Casualty Company, Employers Insurance of Wausau, Aetna Casualty and Surety Company, American Centennial Insurance Company, Granite State Insurance Company, First State Insurance Company, and Northbrook Excess & Surplus Insurance Company (hereinafter “defendants”) — are required to reimburse plaintiff for those recall-related costs to the extent of their respective layers of excess insurance coverage. 3 Defendants North River, Transit Casualty, Employers of Wausau and First State, denying coverage, have moved for summary judgment, in which motion the remaining defendants have joined.

Plaintiff, arguing that coverage exists, has cross-moved for summary judgment as to liability 4 relying essentially on two theories. First, it argues that the language of the excess liability insurance policy at issue here, as construed by the courts, clearly and unambiguously covers recall and recall-related expenses even though neither recall nor anything akin to it is mentioned in the coverage provision of the policy. Second, it argues that if there be ambiguity in the policy, it must be resolved in favor of the insured without resort to extrinsic evidence.

This aversion to extrinsic evidence may perhaps be explained by the fact that at no time until counsel became involved following the recall was there any thought, belief, or intent on the part of Johnson & Johnson or of any party that recall and expenses related thereto, which were neither sought nor paid for, were covered. Rather, in the years preceding the recall, Johnson & Johnson’s Corporate Insurance Department, in Annual Reports to the Board of Directors, unequivocally stated that it maintained no recall coverage whatsoever. Johnson & Johnson, which at one time carried recall coverage, knew such coverage could be purchased, elected not to purchase it because the cost was prohibitive, and now claims that it enjoys recall coverage anyway. These and all other material facts are undisputed and it is similarly undisputed that the issue as to whether recall and recall-related expenses are within the scope of the policy is ripe for summary resolution on the cross motions of the parties.

There are, no doubt, a host of reasons— legal, commercial, and moral — for the massive recall campaign and its various permu *529 tations. The question before the court, however, is whether Johnson & Johnson can quite literally “pass the buck” to its insurers and require them to compensate it, through plaintiff, for the actions which it took. To that question, which itself is proof positive of the adage “nothing ventured, nothing gained,” the answer must be “No”.

I. THE INSURANCE CONTRACT'

In 1977, Johnson & Johnson signed on behalf of itself and its subsidiaries an excess insurance policy with representatives of defendant North River Insurance Company, policy number JU 1081. The terms of the policy with North River are identical to those of the other defendant excess and umbrella insurers, each of which subscribed to an additional layer of coverage. The policies were renewed annually, and the North River policy applicable here was executed on May 13, 1982. 5

The parties contend that the policy language clearly supports their respective positions. The relevant policy language provides as follows:

COVERAGE OR CONDITIONS UMBRELLA LIABILITY
Hit * # * * *
1. COVERAGE
The Company [North River] hereby agree[s], subject to the limitations, terms and conditions hereinafter mentioned, to indemnify the insured [Johnson & Johnson and its subsidiaries] for all Sums which the insured shall be obliged to pay by reason of the liability
(a) imposed upon the insured by law, or
(b) assumed under contract or agreement by the Named Insured and/or any officer, director, stockholder, partner or employee of the Named Insured, while acting in his capacity as such.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Atlantic Mut. Ins. Co. v. Hillside Bottling Co., Inc.
903 A.2d 513 (New Jersey Superior Court App Division, 2006)
Benjamin Moore & Co. v. Aetna Casualty & Surety Co.
843 A.2d 1094 (Supreme Court of New Jersey, 2004)
Universal Underwriters Group v. Pierson
Appellate Court of Illinois, 2003
Cruz-Mendez v. ISU/Insurance Services
722 A.2d 515 (Supreme Court of New Jersey, 1999)
Klein v. Fidelity & Deposit Co. of America
700 A.2d 262 (Court of Special Appeals of Maryland, 1997)
United Technologies Corp. v. American Home Assurance Co.
989 F. Supp. 128 (D. Connecticut, 1997)
Seidenberg v. Mutual Life Insurance Co. of New York
949 F. Supp. 269 (D. New Jersey, 1996)
Ohaus v. Continental Cas. Ins. Co.
679 A.2d 179 (New Jersey Superior Court App Division, 1996)
Metex Corp. v. Federal Ins. Co.
675 A.2d 220 (New Jersey Superior Court App Division, 1996)
Pittston Co. v. Allianz Insurance
905 F. Supp. 1279 (D. New Jersey, 1995)
Sla v. Continisio
17 F.3d 62 (Third Circuit, 1994)
American Casualty Co. of Reading v. Continisio
17 F.3d 62 (Third Circuit, 1994)
Harvard Industries v. AETNA CAS. & SURETY COMPANY
642 A.2d 438 (New Jersey Superior Court App Division, 1993)
Continental Insurance v. Beecham, Inc.
836 F. Supp. 1027 (D. New Jersey, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
645 F. Supp. 525, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcneilab-inc-v-north-river-insurance-njd-1986.